George A. Eldridge, SEE REMARKS at Aerovate Therapeutics, Inc. (AVTE), sold 15,000 shares at $25.03 ($375K) on 2024-06-14, disclosed to the SEC on 2024-06-14.
Scheduled sale ($375k) by SEE REMARKS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| AVTE | SELL | 2024-03-14 | $204K | — | Filing → |
| AVTE | SELL | 2024-03-11 | $736K | — | Filing → |
| AVTE | SELL | 2022-12-13 | $479K | — | Filing → |